Appeals Court Orders FDA To Stay ANDA Approval For Neurontin Generic Capsules
A federal appeals court has ordered the U.S. Food and Drug Administration to stay final approval of the Alpharma's generic version of Pfizer's epilepsy treatment Neurontin pending an appeal....To view the full article, register now.
Already a subscriber? Click here to view full article